Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey.

Guo W, Guo GX, Sun C, Zhang J, Rong Z, He J, Sun ZL, Yan F, Tang YL, Wang CY, Li WB.

Ther Drug Monit. 2013 Dec;35(6):816-22. doi: 10.1097/FTD.0b013e318296a2ff.

PMID:
24263641
2.

Therapeutic drug monitoring in Italian psychiatry.

Conca A, Schmidt E, Pastore M, Hiemke C, Duffy D, Giupponi G.

Pharmacopsychiatry. 2011 Sep;44(6):259-62. doi: 10.1055/s-0031-1286281. Epub 2011 Sep 28.

PMID:
21959788
3.

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.

Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G; Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie..

Pharmacopsychiatry. 2004 Nov;37(6):243-65. Review.

PMID:
15551191
4.

Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.

Norris RL, Martin JH, Thompson E, Ray JE, Fullinfaw RO, Joyce D, Barras M, Jones GR, Morris RG.

Ther Drug Monit. 2010 Oct;32(5):615-23. doi: 10.1097/FTD.0b013e3181ea3e8a.

PMID:
20683393
5.

Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.

Ansermot N, Brawand-Amey M, Kottelat A, Eap CB.

J Chromatogr A. 2013 May 31;1292:160-72. doi: 10.1016/j.chroma.2012.12.071. Epub 2013 Jan 9.

PMID:
23380367
6.

[Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].

Baumann P, Hiemke C, Ulrich S, Eckermann G, Kuss HL, Laux G, Müller-Oerlingenhausen B, Rao ML, Riederer P, Zernig G; AGNP-TDM.; Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) - Therapeutic Drug Monitoring (TDM)..

Rev Med Suisse. 2006 May 24;2(67):1413-8, 1420-2, 1424-6. Review. French.

PMID:
16786958
7.

Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.

Patteet L, Maudens KE, Vermeulen Z, Dockx G, De Doncker M, Morrens M, Sabbe B, Neels H.

Clin Biochem. 2014 Dec;47(18):336-9. doi: 10.1016/j.clinbiochem.2014.09.021. Epub 2014 Oct 5.

PMID:
25289972
8.

A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration.

Couchman L, Belsey SL, Handley SA, Flanagan RJ.

Anal Bioanal Chem. 2013 Nov;405(29):9455-66. doi: 10.1007/s00216-013-7361-8. Epub 2013 Oct 4.

PMID:
24091736
9.

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, Fric M, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Jaquenoud Sirot E, Kirchherr H, Laux G, Lutz UC, Messer T, Müller MJ, Pfuhlmann B, Rambeck B, Riederer P, Schoppek B, Stingl J, Uhr M, Ulrich S, Waschgler R, Zernig G.

Pharmacopsychiatry. 2011 Sep;44(6):195-235. Review.

PMID:
22053351
10.

Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.

Hiemke C.

Eur J Clin Pharmacol. 2008 Feb;64(2):159-66. doi: 10.1007/s00228-007-0430-1. Epub 2008 Jan 15. Review.

PMID:
18196227
11.

Simple and Accurate Quantitative Analysis of 16 Antipsychotics and Antidepressants in Human Plasma by Ultrafast High-Performance Liquid Chromatography/Tandem Mass Spectrometry.

Wang J, Huang H, Yao Q, Lu Y, Zheng Q, Cheng Y, Xu X, Zhou Q, Wu D, Zhang M, Li X, Zhang J.

Ther Drug Monit. 2015 Oct;37(5):649-60. doi: 10.1097/FTD.0000000000000197.

PMID:
26384040
12.

Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.

Baumann P, Hiemke C, Ulrich S, Gaertner I, Rao ML, Eckermann G, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Riederer P, Zernig G.

Ther Drug Monit. 2004 Apr;26(2):167-70.

PMID:
15228159
13.

French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.

Rougemont M, Ulrich S, Hiemke C, Corruble E, Baumann P.

Fundam Clin Pharmacol. 2010 Jun;24(3):377-84. doi: 10.1111/j.1472-8206.2010.00815.x. Epub 2010 Feb 22.

PMID:
20199581
14.

[Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations].

Gerlach M, Rothenhöfer S, Mehler-Wex C, Fegert JM, Schulz E, Wewetzer C, Warnke A.

Z Kinder Jugendpsychiatr Psychother. 2006 Jan;34(1):5-13. German.

PMID:
16485609
15.

Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".

Bengtsson F.

Ther Drug Monit. 2004 Apr;26(2):145-51. Review.

PMID:
15228155
16.

Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?

Hiemke C.

Eur Arch Psychiatry Clin Neurosci. 2008 Mar;258 Suppl 1:21-7. doi: 10.1007/s00406-007-1005-y. Review.

PMID:
18344046
17.

[Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].

Marquet P.

Acta Clin Belg. 1999;53 Suppl 1:2-12. Review. French.

PMID:
10216973
18.

Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.

Aucella F, Lauriola V, Vecchione G, Tiscia GL, Grandone E.

J Pharm Biomed Anal. 2013 Dec;86:123-6. doi: 10.1016/j.jpba.2013.08.001. Epub 2013 Aug 11. Review.

PMID:
23995754
19.

[Therapeutic drug monitoring in epileptology and psychiatry].

Brandt C, Baumann P, Eckermann G, Hiemke C, May TW, Rambeck B, Pohlmann-Eden B.

Nervenarzt. 2008 Feb;79(2):167-74. Review. German.

PMID:
17701390
20.

Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.

Yang Z, Wang S.

J Immunol Methods. 2008 Jul 31;336(2):98-103. doi: 10.1016/j.jim.2008.05.001. Epub 2008 May 27. Review.

PMID:
18547583

Supplemental Content

Support Center